Alendronate [clinicaltrials_resource:ecc4d5ec66b59c4a3896abc96993c35c]
clinicaltrials:NCT00000400clinicaltrials:NCT00000412Effects of Parathyroid Hormone in Men With Osteoporosis [clinicaltrials:NCT00000427]Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis [clinicaltrials:NCT00000430]Treatment of Childhood Osteoporosis With Alendronate (Fosamax) [clinicaltrials:NCT00001720]Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome [clinicaltrials:NCT00001728]Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease [clinicaltrials:NCT00004488]Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis [clinicaltrials:NCT00004489]clinicaltrials:NCT00005005Parathyroid Hormone (PTH) With Alendronate for Osteoporosis [clinicaltrials:NCT00005006]Bone Loss in Premenopausal Women With Depression [clinicaltrials:NCT00006180]clinicaltrials:NCT00010439Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate Cancer [clinicaltrials:NCT00019695]EVA: Evista Alendronate Comparison [clinicaltrials:NCT00035971]clinicaltrials:NCT00043186clinicaltrials:NCT00051558The Effect of Alendronate, Calcium, and Vitamin D on Bone Mineral Density in HIV Infected Patients [clinicaltrials:NCT00061256]A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211) [clinicaltrials:NCT00092014]A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219) [clinicaltrials:NCT00092027]A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907) [clinicaltrials:NCT00092040]A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227) [clinicaltrials:NCT00092066]A Study of MK0217A and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227) [clinicaltrials:NCT00092079]Efficacy of Alendronate Versus Placebo in the Treatment of HIV-associated Osteoporosis (ANRS120) [clinicaltrials:NCT00120757]Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment [clinicaltrials:NCT00122356]OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women [clinicaltrials:NCT00130403]Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol. [clinicaltrials:NCT00138983]Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients [clinicaltrials:NCT00157690]Bone Effects of Teriparatide Following Alendronate [clinicaltrials:NCT00191893]Network Osteoporosis Study [clinicaltrials:NCT00209469]Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss [clinicaltrials:NCT00221312]Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L ) [clinicaltrials:NCT00236002]clinicaltrials:NCT00259857Can Alendronate Suppress Calcification and Improve Bone Density in Chronic Peritoneal Dialysis Patients? [clinicaltrials:NCT00261625]Alendronate in the Prevention of Collapse of Femoral Head in Non-Traumatic Osteonecrosis [clinicaltrials:NCT00265252]Alendronate Osteoporosis Study [clinicaltrials:NCT00277251]clinicaltrials:NCT00293813clinicaltrials:NCT00297830Alendronate for Vascular Calcification in Peritoneal Dialysis Patients? [clinicaltrials:NCT00299572]Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly Alendronate [clinicaltrials:NCT00327990]clinicaltrials:NCT00330460
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Alendronate [clinicaltrials_resource:ecc4d5ec66b59c4a3896abc96993c35c]
Bio2RDF identifier
ecc4d5ec66b59c4a3896abc96993c35c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ecc4d5ec66b59c4a3896abc96993c35c
identifier
clinicaltrials_resource:ecc4d5ec66b59c4a3896abc96993c35c
title
Alendronate
@en
type
label
Alendronate [clinicaltrials_resource:ecc4d5ec66b59c4a3896abc96993c35c]
@en